Sagimet Biosciences Inc. SEC filings SGMT
Sagimet Biosciences Inc. has 262 filings in SEC EDGAR's recent list, going back to May 8, 2007. Its latest annual report, Form ARS, was filed on Apr 21, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 22, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| UPLOAD | Letter from the SEC | May 7, 2025 | — |
| CORRESP | Letter to the SEC | May 5, 2025 | — |
| UPLOAD | Letter from the SEC | Apr 22, 2025 | — |
| EFFECT | Filing | Aug 26, 2024 | — |
| CORRESP | Letter to the SEC | Aug 22, 2024 | — |
| UPLOAD | Letter from the SEC | Aug 19, 2024 | — |
| EFFECT | Filing | Jan 25, 2024 | — |
| CORRESP | Letter to the SEC | Jan 23, 2024 | — |
| CORRESP | Letter to the SEC | Jan 23, 2024 | — |
| UPLOAD | Letter from the SEC | Jan 16, 2024 | — |
| DRS | Filing | Jan 10, 2024 | — |
| SEC STAFF LETTER | Filing | Jul 14, 2023 | — |
| EFFECT | Filing | Jul 13, 2023 | — |
| CERT | Filing | Jul 13, 2023 | — |
| 8-A12B | Filing | Jul 11, 2023 | — |
| CORRESP | Letter to the SEC | Jul 11, 2023 | — |
| CORRESP | Letter to the SEC | Jul 11, 2023 | — |
| CORRESP | Letter to the SEC | Jul 10, 2023 | — |
| SEC STAFF LETTER | Filing | Jul 6, 2023 | — |
| UPLOAD | Letter from the SEC | Jul 6, 2023 | — |
| SEC STAFF LETTER | Filing | May 15, 2023 | — |
| DRS/A | Filing | May 11, 2023 | — |
| DRSLTR | Filing | May 10, 2023 | — |
| DRSLTR | Filing | Apr 25, 2023 | — |
| DRS/A | Filing | Apr 25, 2023 | — |
| UPLOAD | Letter from the SEC | Apr 20, 2023 | — |
| DRS | Filing | Mar 24, 2023 | — |
| RW | Filing | Mar 21, 2022 | — |
| DRS | Filing | Mar 11, 2021 | — |
| D | Filing | Jan 5, 2021 | — |
| D | Filing | Feb 25, 2019 | — |
| D | Filing | Jul 5, 2016 | — |
| D | Filing | Mar 17, 2015 | — |
| D | Filing | Jun 27, 2013 | — |
| D/A | Filing | Dec 20, 2012 | — |
| D | Filing | Dec 12, 2011 | — |
| D | Filing | Jul 22, 2009 | — |
| REGDEX | Auto-generated paper document | May 8, 2007 | — |
Showing 38 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SGMT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Foster City, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1400118
- Former names
- 3-V Biosciences, Inc. (until Feb 25, 2019)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.